Skip to main content

Year: 2022

COMP360 psilocybin therapy shows potential in open-label study in type II bipolar disorder presented at ACNP

12 out of 14 patients went into remission for three months following a single 25mg dose of COMP360 psilocybin therapy, in an independent investigator-initiated, exploratory open-label study of type II bipolar disorder New data from COMPASS’ phase 2b trial, also presented at ACNP, validate potential of COMP360 psilocybin therapy in treatment-resistant depression LONDON, Dec. 08, 2022 (GLOBE NEWSWIRE) — COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced that new positive data demonstrating the potential of COMP360 psilocybin therapy in depression have been presented at the Annual Meeting of the American College of Neuropsychopharmacology (ACNP). The results were presented from an investigator-initiated,...

Continue reading

NNIT A/S: NNIT now expects closing of infrastructure operations divestment in Q1, 2023

The divestment of NNIT’s infrastructure operations to funds managed by Agilitas Private Equity LLP announced on June 22, 2022 is progressing well, and is now expected to close in Q1, 2023, against the initial expectation of closing the transaction six months from announcement, cf. company announcement 9/2022. The transaction requires consent of customers of the infrastructure operation. Most customers have by now rendered their consent, however the updated timeline reflects a few customers’ internal approval processes, which we respect, as well as the pending approval processes with competition authorities and other regulatory authorities. Due to the ongoing divestment process, NNIT will not provide financial guidance for 2022 and expects to update its financial calendar regarding publishing date for annual report for 2022 and date for...

Continue reading

Tearlach Announces Appointment of New Chief Executive Officer and Director

VANCOUVER, British Columbia, Dec. 08, 2022 (GLOBE NEWSWIRE) — Tearlach Resources Limited (TSXV: TEA) (OTC: TELHF) (FRANKFURT: V44) (“Tearlach” or the “Company”) is pleased to announce the appointment of Morgan Lekstrom as its new CEO and Director effective immediately. Mr. Lekstrom has 16 years of mining and industry experience in progressively senior roles in executive management, project management, operations, and engineering management. Prior to joining Tearlach, he was President & CEO of Silver Hammer Mining Corp. and a co-founder of a uranium company, Kraken Energy Corp. Mr. Lekstrom has an established track record of delivering successes across numerous projects, capital raises and defining of strategic direction for multiple companies. He had senior technical roles at Freeport McMoran’s Grasberg site in Indonesia and...

Continue reading

Latest Clinicians’ U.S. Survey Identifies Point of Care Testing (POCT) as a Way to Address Healthcare Bandwidth Pressures and Anticipates Future Growth of POCT in Community Testing Centers

LumiraDx shares these and other findings from its second annual U.S. survey “Point of Care Diagnostics: A Clinician’s View”LumiraDx “Point of Care Diagnostics: A Clinician’s View” US Survey LumiraDx “Point of Care Diagnostics: A Clinician’s View” 2nd Annual US SurveyWALTHAM, Mass., Dec. 08, 2022 (GLOBE NEWSWIRE) — LumiraDx Limited (Nasdaq: LMDX), a next-generation point of care diagnostics company, today announced findings from its second annual “Point of Care Diagnostics: A Clinician’s View” U.S. survey, designed to understand physicians’ perspectives on the latest point of care diagnostics technologies available. This blinded survey polled U.S. physicians on a number of aspects related to point of care testing (POCT) to evaluate key concerns and benefits, testing locations, environmental benefits,...

Continue reading

Point of Care (POC) Survey Reveals Majority of U.K. Clinicians Endorse Climate Benefits of POC Through Reduction of Carbon Emissions and Anticipate Future Growth of POC Testing to Come from Community Settings

LumiraDx shares these and other findings from its first annual U.K. survey “Point of Care Diagnostics: A Clinicians View”LumiraDx UK Survey “Point of Care Diagnostics: A Clinicians View” LumiraDx UK Survey “Point of Care Diagnostics: A Clinicians View”LONDON, Dec. 08, 2022 (GLOBE NEWSWIRE) — LumiraDx Limited (Nasdaq: LMDX), a next-generation point of care diagnostics company, today announced findings from its first annual U.K. survey, “Point of Care Diagnostics: A Clinicians View”, designed to understand clinician perspectives on the latest point of care technologies available. The U.K. blinded survey polled clinicians on a number of areas related to point of care testing (POCT) to evaluate key concerns and benefits, testing locations, environmental benefits, and funding sources. Findings from the survey revealed a few central...

Continue reading

RECHARGE RESOURCES ENVIRONMENTAL PRODUCTION PERMITTING PROCESS UNDERWAY FOR POCITOS 1 LITHIUM BRINE PROJECT

Vancouver, BC, Dec. 08, 2022 (GLOBE NEWSWIRE) — Recharge Resources Ltd. (“Recharge” or the “Company”) (RR: CSE) (RECHF: OTC) (SL50: Frankfurt) is pleased to announce the Company’s geological, consulting and legal teams have commenced the environmental permitting process at the “Pocitos 1” Lithium Brine Project in Salta, Argentina. This is another planned milestone in Recharge’s endeavour to establish a NI 43-101 compliant resource and build up to a 20,000 tonne per year EkoSolve™ lithium extraction plant at Pocitos 1 in order to supply Richlink Capital Pty Ltd. clients up to 20,000 tonnes of lithium chloride per year as previously announced under a letter of intent and framework agreement. Lithium is selling in the spot market at 572,500 Yuan per tonne or the equivalent of US$82,096 per tonne according to TradingEconomics.com....

Continue reading

Alvotech Shares Start Trading on Nasdaq Iceland Main Market

Listing on the Main Market can increase visibility, which may allow the company to appear in both domestic and global indexes Alvotech became first dual-listed Icelandic company in the U.S. and Iceland after market debut in June, trading under the symbol “ALVO“ Robert Wessman Founder and Executive Chairman will ring the Nasdaq Iceland closing bell at 15:30 GMT on December 8, 2022Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced that trading in its shares will move from the Nasdaq Iceland First North Growth market (“First North”) to the Nasdaq Iceland Main Market (“Main Market”), starting today December 8, 2022. The “ALVO” stock market symbol for Alvotech remains unchanged and trade on the Nasdaq U.S. stock exchange is not affected....

Continue reading

With 7.2% CAGR, US Blood Transfusion Diagnostics Market Size worth USD 3.58 Billion by 2029

According to Fortune Business Insights, the global US Blood Transfusion Diagnostics Market size is projected to reach USD 3.58 billion in 2029, at CAGR of 7.2% during forecast period; Rising Demand for Blood and Blood Components to Accelerate the US Blood Transfusion Diagnostics Market Growth Pune, India, Dec. 08, 2022 (GLOBE NEWSWIRE) — The US blood transfusion diagnostics market size was valued at USD 1.91 billion in 2021. The market is projected to grow from USD 2.20 billion in 2022 to USD 3.58 billion by 2029, exhibiting a CAGR of 7.2% during the forecast period. This information is presented by Fortune Business Insights, in its report titled, “US Blood Transfusion Diagnostics Market, 2022-2029.” Key Industry Development: June 2022: Alba Bioscience Limited (QUOTIENT LIMITED) made an announcement that they have been granted...

Continue reading

With 18.2% CAGR, Data Center Automation Market Worth USD 27.35 Billion by 2029

According to Fortune Business Insights, the global data center automation market size is projected to reach USD 27.35 billion in 2029, at a CAGR of 18.2% during the forecast period, 2022-2029 Pune, India, Dec. 08, 2022 (GLOBE NEWSWIRE) — The global data center automation market size was valued at USD 7.40 billion in 2021. The market is expected to grow from USD 8.49 billion in 2022 to USD 27.35 billion by 2029, exhibiting a CAGR of 18.2% during the forecast period. Rising cloud service adoption and increasing demand for developed data center automation are expected to foster this market’s progress. Fortune Business Insights™ mentions this information in its report titled “Data Center Automation Market Forecast, 2022-2029.”Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/data-center-automation-market-107027Key...

Continue reading

Nokia IP and private wireless chosen by Société du Grand Paris to power one of Europe’s largest metro rail projects

Press Release Nokia IP and private wireless chosen by Société du Grand Paris to power one of Europe’s largest metro rail projectsNokia technology forms secure mission-critical communications system behind four Grand Paris Express lines that will transport two million passengers per day. Solutions bring massive capacity, reliability and performance, contributing to Société du Grand Paris’ efforts to boost operations, safety, and rider experience.8 December 2022 Espoo, Finland – Nokia today announced that the Société du Grand Paris (SGP) will deploy its 5G-ready IP/MPLS multiservice, mobile core and radio access network (RAN) solutions to support the implementation of four automated train lines that link 200 kilometers of Paris and up to two million passengers a day. The contract builds on Nokia’s relationship with SGP following the...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.